8h
Zacks Investment Research on MSNUiPath, Inc. (PATH) Is a Trending Stock: Facts to Know Before Betting on ItUiPath (PATH) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
2d
Zacks Investment Research on MSNUiPath Stock is Down 50% in a Year: A Potential Buying Opportunity?UiPath Inc. PATH stock has declined 50% over the past year against the industry's 22% rally. This analysis will explore ...
While the AI boom is still going strong, there are a few reasons to believe that the industry is vastly overselling the ...
UiPath (NYSE:PATH – Get Free Report)‘s stock had its “sector perform” rating reiterated by equities researchers at Royal Bank ...
"The transition in the government that began in January impacted the timing of deal closures," CEO Daniel Dines said.
UiPath's non-GAAP (adjusted) earnings of $0.26 in the quarter were up 13% from the year-ago quarter and easily outpaced Wall Street's consensus estimate of $0.20 per share. But investors mostly ...
Explore more
UiPath's current-quarter and full-year outlooks came up short of estimates as the automated software maker warned of the ...
UiPath's ARR to reach $1.816B in FY26 amid strong AI automation growth. Explore profitability, valuation, and challenges ...
UiPath Inc (NYSE: PATH) stock declined on weak Q4 revenue and Q1 guidance. Needham analyst reiterated Hold. Deal delays and uncertainty in US Fed segment.
UiPath (PATH) has seen its stock hit an all-time low following a bleak revenue forecast issued as a part of its Q4 FY 2025 financial results.
Palantir (NASDAQ: PLTR) has been a rocket ship in the past couple of years. It has delivered returns that many investors ...
Investors should use the technical weakness as a buying opportunity for UiPath stock, as the fundamental setup is currently net positive. Explore more details here.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results